Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Aplin

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
FEBS Letters|January 16, 2003
Cell adhesion molecule regulation of nucleocytoplasmic traffickingAndrew E Aplin
Pigment Cell & Melanoma Research|August 24, 2017
"If you want to go far, go together"Andrew E Aplin
Pigment Cell & Melanoma Research|June 21, 2016
The melanoma field with dendritic rootsAndrew E Aplin
The Journal of Investigative Dermatology|November 11, 2011
Axl of evil?Andrew E Aplin
Current Opinion in Oncology|December 6, 2017
Novel therapeutic strategies and targets in advanced uveal melanomaVivian Chua, Andrew E Aplin
Cancer Discovery|June 2, 2022
Packing a Punch against PD-L1Claudia Capparelli, Andrew E Aplin
Cancer Research|January 16, 2021
Combined SHPments: An Effective Therapeutic Strategy for MPNSTAndrew E Aplin, Claudia Capparelli
Cancer Research|July 22, 2010
Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cellsYongping Shao, Andrew E Aplin
Pigment Cell & Melanoma Research|January 14, 2010
alphaB-crystallin is mutant B-RAF regulated and contributes to cyclin D1 turnover in melanocytic cellsRong Hu, Andrew E Aplin
Pigment Cell & Melanoma Research|January 10, 2015
Game of isoforms: PI3K β-sparing inhibitor is comingHanyin Cheng, Andrew E Aplin
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
FEBS Letters|January 16, 2003
Cell adhesion molecule regulation of nucleocytoplasmic traffickingAndrew E Aplin
Pigment Cell & Melanoma Research|August 24, 2017
"If you want to go far, go together"Andrew E Aplin
Pigment Cell & Melanoma Research|June 21, 2016
The melanoma field with dendritic rootsAndrew E Aplin
The Journal of Investigative Dermatology|November 11, 2011
Axl of evil?Andrew E Aplin
Current Opinion in Oncology|December 6, 2017
Novel therapeutic strategies and targets in advanced uveal melanomaVivian Chua, Andrew E Aplin
Cancer Discovery|June 2, 2022
Packing a Punch against PD-L1Claudia Capparelli, Andrew E Aplin
Cancer Research|January 16, 2021
Combined SHPments: An Effective Therapeutic Strategy for MPNSTAndrew E Aplin, Claudia Capparelli
Cancer Research|July 22, 2010
Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cellsYongping Shao, Andrew E Aplin
Pigment Cell & Melanoma Research|January 14, 2010
alphaB-crystallin is mutant B-RAF regulated and contributes to cyclin D1 turnover in melanocytic cellsRong Hu, Andrew E Aplin
Pigment Cell & Melanoma Research|January 10, 2015
Game of isoforms: PI3K β-sparing inhibitor is comingHanyin Cheng, Andrew E Aplin
Pageof 16